• LAST PRICE
    353.0500
  • TODAY'S CHANGE (%)
    Trending Down-4.5000 (-1.2586%)
  • Bid / Lots
    320.0000/ 1
  • Ask / Lots
    536.3200/ 2
  • Open / Previous Close
    358.7900 / 357.5500
  • Day Range
    Low 352.0300
    High 361.0700
  • 52 Week Range
    Low 249.5000
    High 403.7700
  • Volume
    155,490
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 356.78
TimeVolumeARGX
09:32 ET1348359.81
09:34 ET676360.47
09:36 ET200358.43
09:38 ET400358.02
09:39 ET1010359.15
09:41 ET900360.12
09:43 ET730359.39
09:45 ET400360.7575
09:48 ET1000360.765
09:50 ET300360.62
09:52 ET200359.92
09:54 ET300360.1
09:56 ET100360.0295
09:57 ET400360.68
09:59 ET500359.63
10:06 ET100358.93
10:08 ET100358.86
10:12 ET300358.575
10:14 ET100357.78
10:15 ET300357.945
10:17 ET500357.84
10:19 ET2300357.98
10:21 ET400357.96
10:24 ET1189358.7
10:26 ET100358.91
10:28 ET200358.815
10:32 ET1250359.13
10:33 ET900359.06
10:35 ET100359.2
10:37 ET300359.065
10:39 ET300359.01
10:42 ET1600359.02
10:44 ET200359.13
10:46 ET900358.81
10:48 ET100359.11
10:51 ET900358.58
10:53 ET1000357.98
10:55 ET200358.54
10:57 ET100358.335
11:00 ET400358.4
11:06 ET100358.49
11:08 ET400359.495
11:09 ET1400358.67
11:11 ET300359.15
11:13 ET1200359.15
11:15 ET700359.18
11:18 ET400359.37
11:20 ET400359.71
11:22 ET200360.05
11:24 ET500359.68
11:26 ET1300359.42
11:27 ET500359.28
11:29 ET600359.25
12:09 ET400355.7
12:12 ET100355.78
12:14 ET388355.315
12:16 ET200355.46
12:18 ET300355.36
12:21 ET300356.54
12:23 ET300355.91
12:25 ET300356.065
12:30 ET200356.725
12:32 ET1107357.145
12:34 ET600357.21
12:36 ET1000358.05
12:38 ET200358.345
12:39 ET1308358.405
12:45 ET200357.58
12:54 ET400357.41
12:56 ET200357.905
12:59 ET200357.59
01:06 ET100357.62
01:15 ET300357.99
01:17 ET200357.52
01:33 ET100357.515
01:35 ET200357.255
01:42 ET200357.25
01:53 ET355356.05
01:57 ET100356
02:00 ET383356.145
02:09 ET2060355.79
02:18 ET300356.375
02:24 ET212355.49
02:29 ET300356
02:31 ET100356.005
02:33 ET107355.09
02:36 ET310356.135
02:38 ET300355.67
02:40 ET100355.38
02:42 ET430355.19
02:44 ET100355.095
02:47 ET100354.8
02:49 ET200354.5
02:54 ET300354.22
02:56 ET100354.68
02:58 ET700353.82
03:00 ET100353.715
03:03 ET100354.545
03:12 ET100354.6
03:14 ET100353.84
03:18 ET400354.55
03:20 ET444353.59
03:23 ET100353.855
03:25 ET2600353.26
03:30 ET500353.5
03:32 ET718353.52
03:34 ET600353.14
03:39 ET200353.26
03:41 ET200352.825
03:43 ET100352.25
03:50 ET700353.57
03:52 ET523352.18
03:54 ET1731352.775
03:56 ET1200353.36
03:57 ET1298352.995
03:59 ET1876353.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesARGX
argenx SE
19.1B
-30.8x
---
United StatesALNY
Alnylam Pharmaceuticals Inc
23.7B
-24.5x
---
United StatesBGNE
Beigene Ltd
14.8B
-6.6x
---
United StatesBMRN
Biomarin Pharmaceutical Inc
15.2B
366.2x
---
United StatesBHVN
Biohaven Pharmaceutical Holding Company Ltd
10.9B
-10.2x
---
United StatesTECH
Bio-Techne Corp
11.4B
42.9x
+26.71%
As of 2022-09-30

Company Information

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Contact Information

Headquarters
Willemstraat 5BREDA, Netherlands 4811 AH
Phone
---
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Peter Verhaeghe
Chief Executive Officer, Co-Founder, Executive Director
Tim Van Hauwermeiren
Non-Executive Independent Vice Chairman of the Board
Werner Lanthaler
Chief Financial Officer
Karl Gubitz
Chief Operating Officer
Keith Woods

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.1B
Revenue (TTM)
$362.5M
Shares Outstanding
55.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.86
EPS
$-11.46
Book Value
$49.05
P/E Ratio
-30.8x
Price/Sales (TTM)
52.8
Price/Cash Flow (TTM)
---
Operating Margin
-157.63%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.